By: Marci Greenstein 14 December 2010 Emily Tarsell thought she had enough information about Gardasil — a new vaccine marketed to girls to prevent certain types of cervical cancer — when she agreed to have her daughter receive the vaccine. But after her third and last injection of Gardasil, in 2008, Christina Tarsell, […]
FDA Reviewers Endorse Gardasil for Anal Cancer Prevention
By: Emily P. Walker 15 November 2010 WASHINGTON — Merck’s quadrivalent human papillomavirus recombinant vaccine, Gardasil, appears safe and effective at preventing anal cancer in males and females ages 9 to 26, FDA reviewers said. The vaccine was approved in 2006 to treat genital warts and cervical, vulvar, and vaginal cancer in females ages 9 […]
Gardasil Anal Cancer Indication to Face FDA Advisory Committee Scrutiny
By: S. Sutter 27 September 2010 Merck’s bid to further expand the label for its human papillomavirus vaccine Gardasil – this time for the prevention of anal cancer and anal dysplasia – will face FDA advisory committee scrutiny in November. The Vaccines and Related Biological Products Advisory Committee will meet on Nov. 17 to discuss […]
- « Previous Page
- 1
- …
- 14
- 15
- 16
